EP2452694
Mót-IL-23 mótefni samsetning, aðferðir og notkun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.6.2006EP published:
14.11.2018EP application number:
11190796.0
EP translation filed:
14.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
29.6.2026Expiry date:
29.6.2024
Title:
Anti-IL-23 antibodies, compositions, methods and uses
Timeline
Today
30.6.2006EP application
14.11.2018EP Publication
14.2.2019Translation submitted
15.3.2019Registration published
29.6.2024Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, 19044, Horsham, PA, US
Inventor
Name:
Benson, JacquelineAddress:
Malvern, PA, US
Name:
Cunningham, MarkAddress:
Kennett Square, PA, US
Name:
Duchala, CynthiaAddress:
North Wales, PA, US
Name:
Giles-Komar, Jill M.Address:
Downingtown, PA, US
Name:
Luo, JinquanAddress:
Malvern, PA, US
Name:
Rycyzyn,, Michael A.Address:
Berwyn, PA, US
Name:
Sweet, RaymondAddress:
Bala Cynwyd, PA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
695831 PDate:
30.6.2005Country:
US
Classification
Categories:
A61K 39/395, G01N 33/567, C07H 21/04, C12P 21/06, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 8.5.2019
Expires: 29.6.2020
Payer: Árnason Faktor
Number: 15
Paid: 5.5.2020
Expires: 29.6.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.5.2021
Expires: 29.6.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 6.5.2022
Expires: 29.6.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 24.5.2023
Expires: 29.6.2024
Payer: Árnason Faktor ehf.